Neil Breslin, who served 28 years as in the New York State Senate, is expected to continue as a resource for regulating the ...
Opinion
Editorial Roundup: United States
Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...
The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...
The National Community Pharmacists Association has joined a class action lawsuit against GoodRx, as well as CVS Caremark, ...
The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...
In the days leading up to President Trump’s inauguration, the Biden FTC rushed to initiate major lawsuits and to tie a bow on ...
Hollywood-based AIDS Healthcare Foundation has won a $10.3 million arbitration award in a dispute with a pharmacy benefit ...
President Trump has chosen Gail Slater to lead the U.S. Department of Justice (DOJ) Antitrust Division and elevated Commissioner Andrew Ferguson ...
Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...
An activist shareholder is planning a proxy battle at United States Steel Corp. to force the end of the controversial $14.9 ...
Evercore ISI raised the firm’s price target on CVS Health (CVS) to $65 from $60 and keeps an Outperform rating on the shares. Given 2025 will ...
The second week of the Legislative Session brings more work on pieces of legislation. I was excited to have my first ...